Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference
Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the Guggenheim Securities Healthcare Innovation ...
FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic ...
This represents the fourth indication granted a Breakthrough Device Designation for the SCD by FDA DENVER, Nov. 06, 2024 ...